Fenofibrate Tablet, Film Coated
Product Images NDC 46708-361

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 46708-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibrate-145-mg.jpg (Fenofibrate 145 mg)

Label for Fenofibrate Tablets USP 145 mg film-coated tablets, oral use. The package contains 30 tablets and is manufactured by Alembic Pharmaceuticals Limited. Storage instructions recommend 25°C (77°F) with allowed excursions from 15° to 30°C (59° to 86°F). The label includes information about seal integrity and dispensing in a USP tight container.*

FDA Label Image

Fenofibrate-48-mg.jpg (Fenofibrate 48 mg)

Label for Fenofibrate Tablets, USP 48 mg, oral film-coated tablets. The label indicates the package contains 30 tablets, manufactured by Alembic Pharmaceuticals Limited. Storage instructions and NDC 46708-360-30 are also displayed along with a barcode and lot/expiration date fields.*

FDA Label Image

Structure (Fenofibrate Structure)

Chemical structure diagram of fenofibrate, showing its molecular composition with aromatic rings and functional groups. This structure corresponds to the active ingredient fenofibrate used in prescription tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.